You searched for "therapeutics"

530 results found

Head and neck cancer deaths to cost $535 billion by 2030

More than 500,000 people across the globe will die this year from head and neck cancer, which is the sixth most common cancer in the world and comprises malignancies of the nose, mouth, throat, larynx, and neck. Assuming current trends...

A global online fellowship in head and neck surgery and oncology

The International Federation of Head and Neck Oncologic Societies (IFHNOS) offers an online fellowship training programme for advanced trainees wishing to subspecialise in head and neck surgery and oncology. Emma Stapleton speaks with the Chairman of the Board of Directors...

Patient-centred and accelerating progress: two organisations changing the landscape for rare skull base tumours

Patient-led organisations are transforming care for rare skull base tumours by connecting patients, clinicians and researchers to accelerate diagnosis, support and scientific progress. A skull base tumour diagnosis is a difficult time for any patient, but it is made more...

In conversation with Professor Gerry O’Donoghue

On the occasion of his retirement from the Nottingham Auditory Implant Programme, we discuss his pioneering work in cochlear implantation and the challenges involved. ENT News author picture, 1993. Why did you choose a career in ENT? I started off...

Experience on the front line

21st January 2021 Back to basics Yesterday I went right back to where my medical career began. I grew up in Germany, bilingual. A prerequisite to studying medicine in Germany is that applicants have to spend two months working as...

Royal Society of Medicine – new presidents, new programme

Exciting changes are occurring at the ENT section of the Royal Society of Medicine over the next academic year. Professor Peter Rea and Professor Claire Hopkins, the incoming presidents of the Otology and the Laryngology & Rhinology Sections, have come together to create a combined programme.

Robotic surgery for squamous cell cancer: the new frontiers

Although the da Vinci platform was FDA approved for early-stage oropharyngeal cancers, the indications have expanded. In this article, John Hardman explains how surgeons, with greater understanding of the strengths and limitations of robotic surgery, have systematically set out to...

In conversation with Miss Sujata De: Chair of the ESPO 2023 Local Programme Committee

Su De is one of the UK’s most prominent paediatric ORL surgeons, and has a leading role in planning ESPO 2023. Hannah Emerson caught up with Su recently to explore some of her thoughts and her plans for ESPO. You’ve...

Selecting and optimising hearing aids for tinnitus benefit: a rough guide

Hearing aids have a relatively long history as tinnitus treatment tools. Saltzman and Ersner reported success in suppressing tinnitus with simple hearing aids in a number of cases as early as 1947 [1]. In an early comprehensive approach to tinnitus...

Hearing, tinnitus and hyperacusis in the arts

Hearing loss, tinnitus and hyperacusis are discussed by David Baguley from the unique perspective of their depictions in literature, music, film and paintings. This article provides unusual and invaluable reflective opportunities for the patient-centred clinician! Audiologists and otologists understand hearing...

Physiological mechanisms of hyperacusis: an update

Hyperacusis is a heterogeneous and complex clinical entity, and proposals about physiological mechanisms should reflect these issues. Ben Auerbach helps us navigate through present knowledge in this area, and proposes future directions for research. Hyperacusis is a debilitating hearing disorder...

Hearing loss and cognition: something to think about

Irace, Chern and Golub propose causal and non-causal mechanisms for the links between hearing loss and dementia, concluding with a discussion of several proactive measures available to help preserve neurocognitive health in older adults with hearing loss. What is age-related...